This bibliometric and knowledge-mapping analysis will evaluate the research landscape of PDE-4 inhibitor therapy in inflammatory dermatologic diseases. The study will identify publication trends, leading authors and institutions, and evolving research themes involving agents such as apremilast, crisaborole, and roflumilast across major inflammatory skin disorders.
Click-Here-(Apply Form).comCall for Co-AuthorsWe are pleased to announce an open call for:
8 Co-authorship slots on our upcoming cross sectional.
• Prior research or publication experience is not required, we welcome new authors.
• Open to medical students (undergraduate and postgraduate), residents, and MDs.
• This is an excellent opportunity to gain authorship experience and contribute to a published work.
Deadline: January 15, 2026, at 11:59 PMFill out the form at the link above.
Slots are limited please apply promptly.